Envestnet Portfolio Solutions
VRTX icon

Envestnet Portfolio Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Envestnet Portfolio Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01M Sell
8,064
-633
-7% -$281K 0.02% 369
2026
Q1 		$3.88M Sell
8,697
-7,772
-47% -$3.62M 0.02% 328
2025
Q4 		$7.47M Sell
16,469
-1,752
-10% -$755K 0.03% 298
2025
Q3 		$7.14M Buy
18,221
+927
+5% +$387K 0.03% 284
2025
Q2 		$7.7M Buy
17,294
+272
+2% +$125K 0.03% 268
2025
Q1 		$8.25M Sell
17,022
-2,227
-12% -$1.04M 0.03% 264
2024
Q4 		$7.75M Sell
19,249
-17,777
-48% -$8.24M 0.03% 299
2024
Q3 		$17.2M Sell
37,026
-651
-2% -$313K 0.06% 166
2024
Q2 		$17.7M Buy
37,677
+1,249
+3% +$542K 0.06% 155
2024
Q1 		$15.2M Buy
36,428
+4,511
+14% +$1.91M 0.06% 173
2023
Q4 		$13M Buy
31,917
+613
+2% +$226K 0.05% 178
2023
Q3 		$10.9M Buy
+31,304
New +$10.9M 0.05% 173

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Envestnet Portfolio Solutions's VRTX Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its Vertex Pharmaceuticals (VRTX) stake by 7.3% in Q2 2026, selling an estimated $281K and leaving 8,064 shares worth $4.01M. The position accounts for 0.02% of the portfolio, ranked #369.

Envestnet Portfolio Solutions first reported a position in VRTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $17.7M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Envestnet Portfolio Solutions held 8,064 shares of Vertex Pharmaceuticals worth $4.01M as of Q2 2026.
  • Envestnet Portfolio Solutions sold 633 Vertex Pharmaceuticals shares in Q2 2026, an estimated $281K.
  • Vertex Pharmaceuticals made up 0.02% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #369 holding.
  • Envestnet Portfolio Solutions first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Vertex Pharmaceuticals position peaked at $17.7M in Q2 2024.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.